Use of artificial intelligence as a diagnostic support tool for skin lesions in primary care: feasibility study in clinical practice. (Preprint)
Authors: Escalé-Besa Anna , Yélamos Oriol , Vidal-Alaball Josep , Fuster-Casanovas Aïna , Miró Catalina Queralt , Börve Alexander , Ander-Egg Aguilar Ricardo , Fustà-Novell Xavier , Cubiró Xavier , Esquius Rafat Mireia , López-Sanchez Cristina , Marin-Gomez Francesc X 
Published: January 2023

BACKGROUND

Dermatological conditions are a relevant health problem. Machine learning (ML) models are increasingly being applied to dermatology as a diagnostic decision support tool using image analysis, especially for skin cancer detection and disease classification.  

OBJECTIVE

The objective of this study was to perform a prospective validation of an image analysis ML model, which is capable of screening 44 skin diseases, comparing its diagnostic accuracy with that of General Practitioners (GPs) and teledermatology (TD) dermatologists in a real-life setting.

METHODS

Prospective, diagnostic accuracy study including 100 consecutive patients with a skin problem who visited a participating GP in central Catalonia, Spain, between June 2021 and October 2021.   
The skin issue was first assessed by the GPs. Then an anonymised skin disease picture was taken and uploaded to the ML application, which returned a list with the Top-5 possible diagnosis in order of probability. The same image was then sent to a dermatologist via TD for diagnosis, as per clinical practice. The GPs Top-3, ML model’s Top-5 and dermatologist’s Top-3 assessments were compared to calculate the accuracy, sensitivity, specificity and diagnostic accuracy of the ML models.

RESULTS

The overall Top-1 accuracy of the ML model (39%) was lower than that of GPs (64%) and dermatologists (72%). When the analysis was limited to the diagnoses on which the algorithm had been explicitly trained (n=82), the balanced Top-1 accuracy of the ML model increased (48%) and in the Top-3 (75%) was comparable to the GPs Top-3 accuracy (76%). The Top-5 accuracy of the ML model (89%) was comparable to the dermatologist Top-3 accuracy (90%).
For the different diseases, the sensitivity of the model (Top-3 87% and Top-5 84%) is higher than that of the clinicians (Top-3 GPs 76% and Top-3 dermatologists 84%) only in the benign tumour pathology group, being on the other hand the most prevalent category (n=53).   
About the satisfaction of professionals, 92% of the GPs considered it as a usefuldiagnostic support tool (DST) for the differential diagnosis and in 60% of the cases as an aid in the final diagnosis of the skin lesion.

CONCLUSIONS

The overall diagnostic accuracy of the model in this study under real conditions is lower than that of both GPs and dermatologists, a fact that is consistent with the few existing prospective studies under real conditions. These results highlight the potential of the ML models to assist GPs as a DST for skin conditions especially in the differential diagnosis. However, external testing in real conditions is essential for data validation and regulating these AI diagnostic models, in order to deploy ML models in a Primary Care setting.

CLINICALTRIAL

The clinical trial has been approved by the IDIAP Jordi Gol i Gurina ethics committee with code 20-159P.  
Clinicaltrials.gov NCT04562168; https://clinicaltrials.gov/ct2/show/NCT04562168 (Archived by WebCite at http://www.webcitation.org/6V0tto0lZ).  
JMIR Res Protoc 2022;11(8):e37531 doi:10.2196/37531